Cell migration represents a fundamental physiological process that is intricately linked to cancer biology. The movement of cells is governed by dynamic interactions with the extracellular matrix (ECM ...

Iron metabolism represents a key area of cancer research, as iron is crucial for cellular proliferation and many metabolic processes. Tumors often exhibit ...

A common vitamin may be quietly helping cancer cells evade death. The body depends on vitamin B2, also called riboflavin, but ...

HMGA2 is a non-histone chromatin-binding protein that has emerged as a critical regulator in both cancer progression and stem cell biology. Frequently overexpressed in various malignancies, HMGA2 ...

It is well known that chronic inflammation can increase a person’s cancer risk, but the underlying mechanisms remain unknown. Now, a new study reveals, in a mouse model of colitis, gut tissues may ...

The vitamin B2 (riboflavin) must be absorbed through diet: it can be found in dairy products, eggs, meat, and green vegetables. The body’s metabolism converts vitamin B2 into molecules that protect ...

The study of mutant p53 isoforms lies at the forefront of cancer biology, revealing the profound impact of TP53 gene alterations on tumor progression and ...

Cooper Medical School of Rowan University (CMSRU) has launched the PhD in Cancer Cell Biology & Genomics (CCBG), a new ...

Scientists have discovered that a rare “mirror-image” version of the amino acid cysteine can dramatically slow the growth of certain cancers while leaving healthy cells largely untouched. Unlike most ...

Cancer’s deadliest talent is not rapid growth but the ability to sidestep the internal programs that should make damaged cells self-destruct. Across multiple labs, researchers are now converging on a ...

Cancer cells have fewer heavy hydrogen atoms in their lipids as compared to healthy cells. The finding unearths a potential geochemical tool for cancer diagnosis in the future. As the daughter of a ...

Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...